Unlock stock picks and a broker-level newsfeed that powers Wall Street.
33.84
-2.37
(-6.55%)
At close: April 1 at 4:00:00 PM EDT
34.29
+0.45
+(1.33%)
Pre-Market: 4:02:28 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 10 |
| Avg. Estimate | -1.62 | -1.35 | -5.36 | -3.46 |
| Low Estimate | -2.41 | -1.58 | -6.42 | -4.79 |
| High Estimate | -1.18 | -1.03 | -3.9 | -0.22 |
| Year Ago EPS | -2.03 | -1.52 | -6.29 | -5.36 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 19 | 19 |
| Avg. Estimate | 145.98M | 163.67M | 656.56M | 846.66M |
| Low Estimate | 127M | 155.5M | 636.6M | 709.7M |
| High Estimate | 165.4M | 174.7M | 673M | 1.02B |
| Year Ago Sales | 108.83M | 147.03M | 560.23M | 656.56M |
| Sales Growth (year/est) | 34.13% | 11.32% | 17.19% | 28.95% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.72 | -1.63 | -1.47 | -1.27 |
| EPS Actual | -2.03 | -1.52 | -1.4 | -1.39 |
| Difference | -0.31 | 0.11 | 0.07 | -0.12 |
| Surprise % | -18.01% | 6.90% | 4.96% | -9.45% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.62 | -1.35 | -5.36 | -3.46 |
| 7 Days Ago | -1.62 | -1.38 | -5.43 | -3.6 |
| 30 Days Ago | -1.62 | -1.35 | -5.38 | -3.6 |
| 60 Days Ago | -1.33 | -1.25 | -5.07 | -3.5 |
| 90 Days Ago | -1.36 | -1.28 | -5.13 | -3.62 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | -- |
| Up Last 30 Days | 1 | 3 | 1 | 1 |
| Down Last 7 Days | 2 | 2 | -- | -- |
| Down Last 30 Days | 6 | 4 | 4 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RARE | 20.20% | 10.97% | 14.86% | 35.39% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 10/22/2024 |
| Maintains | TD Cowen: Buy to Buy | 10/21/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 10/1/2024 |
| Reiterates | RBC Capital: Outperform to Outperform | 9/26/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/20/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/16/2024 |
Related Tickers
AGIO Agios Pharmaceuticals, Inc.
27.40
-6.48%
CRNX Crinetics Pharmaceuticals, Inc.
30.62
-8.71%
PTCT PTC Therapeutics, Inc.
46.60
-8.56%
SWTX SpringWorks Therapeutics, Inc.
41.88
-5.10%
RYTM Rhythm Pharmaceuticals, Inc.
50.00
-5.61%
MREO Mereo BioPharma Group plc
2.1700
-3.56%
NUVL Nuvalent, Inc.
68.00
-4.12%
CYTK Cytokinetics, Incorporated
37.50
-6.69%
RNA Avidity Biosciences, Inc.
26.74
-9.42%
ASND Ascendis Pharma A/S
151.43
-2.84%